What is Pibrentasvir and its relevance to hepatitis C and potential for COVID-19 treatment?
Label:chem
Topic
Compound: Pibrentasvir
Answer
Pibrentasvir inhibits HCV NS5A, a protein crucial for the replication, assembly, and maturation of infectious viral proteins. It is indicated for patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection with or without compensated cirrhosis. In this study, it exhibited a high binding affinity of 9.4 with COVID-19 protease, suggesting its potential as a COVID-19 protease inhibitor.
Return to Home
Chemical List
Knowledge you may be interested in